Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators
Citations Over Time
Abstract
Accumulation of aberrant protein aggregates, such as amyloid beta peptide (Aβ), due to decreased proteasome activities might contribute to the neurodegeneration in Alzheimer's disease. In this study, lithocholic acid derivatives 3α-O-pimeloyl-lithocholic acid methyl ester (2) and its isosteric isomer (6) were found to activate the chymotrypsin-like activity of the proteasome at an EC(50) of 7.8 and 4.3 μM, respectively. Replacing the C24 methyl ester in 2 with methylamide resulted in a complete devoid of proteasome activating activity. Epimerizing the C3 substituent from an alpha to beta orientation transformed the activator into a proteasome inhibitor. Unlike the cellular proteasome activator PA28, proteasome activated by 2 was not inhibited by Aβ. Furthermore, 2 potently antagonized the inhibitory effect of Aβ on the proteasome. In summary, compound 2 represents a novel class of small molecules that not only activates the proteasome but also antagonizes the inhibitory effect of Aβ on the proteasome.
Related Papers
- → Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbit(1974)102 cited
- → Synthesis and mesomorphic behaviour of lithocholic acid derivatives(2003)4 cited
- → Synthetic studies of vitamin D3analogues from bile acids. Part 3. Syntheses of 1α,25-, 1α,24R-, and 1α,24S-dihydroxycholecalciferols from lithocholic acid and their biological activities(1979)8 cited
- → Dietary Bile Acids and Lipid Metabolism. V. Reversibility of the Effects of Lithocholic Acid in Chicks(1964)6 cited
- → Comparative Study of the Liver of Rats treated with Cholic and Lithocholic Acid, alone or associated with Butter-yellow(1967)2 cited